HEERLEN, The Netherlands and LONDON, March 31, 2016 /PRNewswire/ --
Today DocMorris, in collaboration with Aegate, announces the implementation of a medicine authentication system that will allow it to meet the legal requirements of the EU Falsified Medicines Directive (FMD). By acting now, prior to the February 2019 deadline for application of the FMD, DocMorris will be the first mail order pharmacy in Europe to be able to put the FMD into daily routine at the pharmacy - to the benefit of their patients.
Under the FMD manufacturers will have to provide individual pack safety features via a serialised code and tamper evident seal that meet EU specifications. These elements can now be tested. To do this Aegate has developed a demonstrator, that shows the end-to-end-authentication process from the manufacturer to the pharmacy which is the dispensing point. The benefit for the pharmaceutical manufacturers: Thanks to the cooperation between Aegate, the worldwide leading specialist in medication authentication, and Europe's largest mail order pharmacy DocMorris pharmaceutical manufactures will be able to check, their serialisied medicine packs under real conditions.
Verification occurs using the technical connection to an authentication platform by Aegate, one of the selected National Blueprint providers in Europe. The Aegate platform fully meets the specifications of the directive, and both pharmacies and mail order pharmacies can connect to the European-wide system.
For years, DocMorris has supported measures that strengthen medication security at both a European and national level. "As the most modern pharmacy in Europe, it is clear that we want to be the pioneer in implementing the guidelines from the Falsified Medicines Directive to offer our patients the maximum level of protection when purchasing medications. The Aegate platform, which can be easily integrated in our current pharmaceutical system, guarantees maximum security even with a huge amount of daily authentication requests," said Prof. Dr. Christian Franken, Head Pharmacist and Chief Pharmaceutical Officer at DocMorris. The mail order pharmacy dispenses more than 20,000 prescription medicine packs to consumers in Germany every day.
"An uninterrupted verification process from the manufacturer up to the dispensing is the perfect way to discover falsified medicines," said Mark de Simone, Aegate CEO. "With our system we are protecting the health of patients. Furthermore, we offer pharmaceutical manufacturers an effective and efficient implementation of the European Falsified Medicines Directive in time." Aegate already checks 2.5 million transactions a day - in less than a quarter of a second response time for the dispensing pharmacist. The British company is active in 13 European countries and, with its system, has verified over 3.9 billion medicine packs in recent years.
Commercial Director Aegate Ltd
Cambridge Technology Centre
Melbourn SG8 6DP UK